TY - JOUR
T1 - No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO)
AU - Beekman, Maarten J.
AU - Terra, Lara
AU - Roeters van Lennep, Jeanine E.
AU - Heemskerk-Gerritsen, Bernadette A.M.
AU - van Beurden, Marc
AU - van Doorn, Helena C.
AU - de Hullu, Joanne A.
AU - van Dorst, Eleonora B.L.
AU - Mom, Constantijne H.
AU - Slangen, Brigitte F.M.
AU - Mourits, Marian J.E.
AU - Gaarenstroom, Katja N.
AU - van Engelen, Klaartje
AU - van der Kolk, Lizet E.
AU - Collée, J. Margriet
AU - Wevers, Marijke R.
AU - Ausems, Margreet G.E.M.
AU - Berger, Lieke P.V.
AU - Gomez Garcia, Encarna B.
AU - van Asperen, Christi J.
AU - Hooning, Maartje J.
AU - van Leeuwen, Flora E.
AU - Maas, Angela H.E.M.
N1 - Funding Information:
The Dutch Cancer Society (KWF) and the Maarten van der Weijden foundation granted us with the funding for this project, registered under grant 10164. The funding body had no role in the design of the study, collection, analysis or interpretation of data or in writing the article.
Publisher Copyright:
© 2025
PY - 2025/6/1
Y1 - 2025/6/1
N2 - Objective: Women at high familial risk of ovarian cancer are recommended to undergo premenopausal risk-reducing salpingo-oophorectomy (RRSO). The procedure leads to immediate surgical menopause, and while early natural menopause is associated with an increase in the risk of cardiovascular disease (CVD), evidence on CVD risk after surgical menopause is inconsistent. Main outcome measures: To investigate the long-term CVD risk after surgical menopause we conducted a cross-sectional study comparing a group of women who underwent a premenopausal RRSO (=45 years) with a group who underwent postmenopausal RRSO (=54 years). We assessed arterial stiffness, measured by pulse wave velocity (PWV). Increased PWV has been shown to be an independent predictor for CVD. Age differences between the pre- and postmenopausal RRSO groups were accounted for by restricting analyses to women aged 60–70 at study visit (n = 307). Within the premenopausal RRSO group (n = 461), we also examined the effect of timing of premenopausal RRSO on PWV (RRSO<41 vs RRSO 41–45 years). In addition, we assessed the association between PWV and coronary artery calcium (CAC) in women who underwent premenopausal RRSO. Results: In women aged 60–70 at study visit, PWV levels were significantly lower in the premenopausal RRSO group compared with the postmenopausal RRSO group (ß: -0.87, 95 % CI, -1.45, -0.28 for PWV level; RR: 0.47, 95 % CI, 0.24, 0.93 for being in the upper PWV quintile). The timing of premenopausal RRSO did not influence PWV. Among all women who underwent premenopausal RRSO, having a PWV in the upper quintile was an independent predictor of the presence of CAC (RR 1.32, 95 % CI, 1.04–1.68 for CAC > 0). Conclusion: Our study does not support a long-term adverse effect of premenopausal RRSO on arterial stiffness, but increased arterial stiffness is associated with the presence of CAC in women who have undergone a premenopausal RRSO. Clinical trial registration: The pre-registered clinical trial number is .
AB - Objective: Women at high familial risk of ovarian cancer are recommended to undergo premenopausal risk-reducing salpingo-oophorectomy (RRSO). The procedure leads to immediate surgical menopause, and while early natural menopause is associated with an increase in the risk of cardiovascular disease (CVD), evidence on CVD risk after surgical menopause is inconsistent. Main outcome measures: To investigate the long-term CVD risk after surgical menopause we conducted a cross-sectional study comparing a group of women who underwent a premenopausal RRSO (=45 years) with a group who underwent postmenopausal RRSO (=54 years). We assessed arterial stiffness, measured by pulse wave velocity (PWV). Increased PWV has been shown to be an independent predictor for CVD. Age differences between the pre- and postmenopausal RRSO groups were accounted for by restricting analyses to women aged 60–70 at study visit (n = 307). Within the premenopausal RRSO group (n = 461), we also examined the effect of timing of premenopausal RRSO on PWV (RRSO<41 vs RRSO 41–45 years). In addition, we assessed the association between PWV and coronary artery calcium (CAC) in women who underwent premenopausal RRSO. Results: In women aged 60–70 at study visit, PWV levels were significantly lower in the premenopausal RRSO group compared with the postmenopausal RRSO group (ß: -0.87, 95 % CI, -1.45, -0.28 for PWV level; RR: 0.47, 95 % CI, 0.24, 0.93 for being in the upper PWV quintile). The timing of premenopausal RRSO did not influence PWV. Among all women who underwent premenopausal RRSO, having a PWV in the upper quintile was an independent predictor of the presence of CAC (RR 1.32, 95 % CI, 1.04–1.68 for CAC > 0). Conclusion: Our study does not support a long-term adverse effect of premenopausal RRSO on arterial stiffness, but increased arterial stiffness is associated with the presence of CAC in women who have undergone a premenopausal RRSO. Clinical trial registration: The pre-registered clinical trial number is .
KW - Estrogen deficiency
KW - Ovarian cancer - surgical menopause
KW - Pulse wave velocity - cardiovascular disease
U2 - 10.1016/j.maturitas.2025.108265
DO - 10.1016/j.maturitas.2025.108265
M3 - Article
SN - 0378-5122
VL - 197
JO - Maturitas
JF - Maturitas
M1 - 108265
ER -